ACADIA Pharmaceuticals Inc (ACAD)
Receivables turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 957,797 | 726,437 | 517,235 | 484,145 | 441,755 |
| Receivables | US$ in thousands | — | — | — | — | — |
| Receivables turnover | — | — | — | — | — |
December 31, 2024 calculation
Receivables turnover = Revenue ÷ Receivables
= $957,797K ÷ $—K
= —
Unfortunately, the provided data does not include information on ACADIA Pharmaceuticals Inc's receivables turnover for the years 2020, 2021, 2022, 2023, and 2024. Receivables turnover is a crucial financial ratio that measures a company's effectiveness in collecting outstanding receivables from customers. Without this data, it is challenging to assess ACADIA Pharmaceuticals Inc's efficiency in managing its accounts receivable during the specified period. A high receivables turnover ratio generally indicates that the company is efficiently collecting payments from its customers, while a low ratio may suggest potential issues with credit policies or collection procedures. With the data provided showing that the receivables turnover ratio is not available for the specified period, it is recommended to obtain this information to conduct a more comprehensive analysis of the company's financial performance and liquidity management.
Peer comparison
Dec 31, 2024